This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug BOOSTRIX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Diphtheria toxoid adsorbed
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
|
|
|
|
2
Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
|
| 3 Purified pertussis toxoid (PT XD) |
|
|
|
4
Filamentous hemagglutinin (FHA)
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
|
|
5
Pertactin (69-KDA outer membrane protein-69K)
UNII 2QNL82089R - BORDETELLA PERTUSSIS
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BOOSTRIX Suspension for injection in pre-filled syringe | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AJ52 | Pertussis, purified antigen, combinations with toxoids | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 78-MBE-1116 |
| Country: EE | Ravimiamet | Identifier(s): 1282799, 1282801, 1282812, 1282823, 1282834, 1282845, 1282856, 1282867, 1282878, 1282889 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 63684 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 005085, 005096 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 62404793 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 262677 |
| Country: HK | Department of Health Drug Office | Identifier(s): 48297 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6404 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1008858, 1089092, 1089093, 1089094, 1089095, 1089096, 1089097, 1089098, 1089099, 1089100, 1089101, 1089102, 1089103, 1089104, 1089105, 1089106, 1091088 |
| Country: MT | Medicines Authority | Identifier(s): MA170/00101, MA170/00104 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14983842 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 167827 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11307 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100211343 |
| Country: SG | Health Sciences Authority | Identifier(s): 11845P, 13187P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7063161 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522967568 |
| Country: US | FDA, National Drug Code | Identifier(s): 50090-1377, 50090-1831, 58160-842 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 43/30.2/0526, 49/30.2/1042 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
